Correlation between variants of the CREB1 and GRM7 genes and risk of depression

[1]  M. Zimmerman,et al.  The relative importance of diagnostic specific and transdiagnostic factors in evaluating treatment outcome of depressed patients , 2022, Psychiatry Research.

[2]  A. Gu,et al.  Air pollution, genetic factors and the risk of depression. , 2022, The Science of the total environment.

[3]  Shaoming Li,et al.  Bioactive human Alzheimer brain soluble Aβ: pathophysiology and therapeutic opportunities , 2022, Molecular Psychiatry.

[4]  Dong Qi,et al.  Bioinformatics Analysis of Potential Biomarkers and Pathway Identification for Major Depressive Disorder , 2021, Computational and mathematical methods in medicine.

[5]  Fei Yang,et al.  Intranasal treatment of lixisenatide attenuated emotional and olfactory symptoms via CREB-mediated adult neurogenesis in mouse depression model. , 2021, Aging.

[6]  S. Mishra,et al.  Memantine treatment exerts an antidepressant-like effect by preventing hippocampal mitochondrial dysfunction and memory impairment via upregulation of CREB/BDNF signaling in the rat model of chronic unpredictable stress-induced depression , 2020, Neurochemistry International.

[7]  Yong Zhang,et al.  CREB1 and BDNF gene polymorphisms are associated with early treatment response to escitalopram in panic disorder. , 2020, Journal of affective disorders.

[8]  Tingting Gao,et al.  Interactions of childhood maltreatment and genetic variations in adult depression: A systematic review. , 2020, Journal of affective disorders.

[9]  Yulan Liu,et al.  MicroRNA-202-3p Targets Brain-Derived Neurotrophic Factor and Is Involved in Depression-Like Behaviors , 2020, Neuropsychiatric disease and treatment.

[10]  Z. Miao,et al.  Tanshinone IIA Improves Depression-like Behavior in Mice by Activating the ERK-CREB-BDNF Signaling Pathway , 2020, Neuroscience.

[11]  M. Shabani,et al.  Hippocampal and prefrontal cortical NMDA receptors mediate the interactive effects of olanzapine and lithium in memory retention in rats: the involvement of CAMKII-CREB signaling pathways , 2020, Psychopharmacology.

[12]  M. Shabani,et al.  Hippocampal and prefrontal cortical NMDA receptors mediate the interactive effects of olanzapine and lithium in memory retention in rats: the involvement of CAMKII-CREB signaling pathways , 2020, Psychopharmacology.

[13]  M. Taheri,et al.  Glutamate receptor metabotropic 7 (GRM7) gene polymorphisms in mood disorders and attention deficit hyperactive disorder , 2019, Neurochemistry International.

[14]  G. He,et al.  GRIK4 and GRM7 gene may be potential indicator of venlafaxine treatment reponses in Chinese of Han ethnicity , 2019, Medicine.

[15]  Q. Gong,et al.  Voxel-wise meta-analysis of task-related brain activation abnormalities in major depressive disorder with suicide behavior , 2019, Brain Imaging and Behavior.

[16]  P. Masand,et al.  Neuroplasticity, Neurotransmission and Brain-Related Genes in Major Depression and Bipolar Disorder: Focus on Treatment Outcomes in an Asiatic Sample , 2018, Advances in Therapy.

[17]  Chen Zhang,et al.  The cAMP responsive element-binding (CREB)-1 gene increases risk of major psychiatric disorders , 2018, Molecular Psychiatry.

[18]  A. Yang,et al.  Gene-based analysis of genes related to neurotrophic pathway suggests association of BDNF and VEGFA with antidepressant treatment-response in depressed patients , 2018, Scientific Reports.

[19]  Blair H. Smith,et al.  Genome-wide Regional Heritability Mapping Identifies a Locus Within the TOX2 Gene Associated With Major Depressive Disorder , 2017, Biological Psychiatry.

[20]  L. Haupt,et al.  A CREB1 Gene Polymorphism (rs2253206) Is Associated with Prospective Memory in a Healthy Cohort , 2017, Front. Behav. Neurosci..

[21]  Christopher E. Gonzalez,et al.  Cross-Sectional and Longitudinal Effects of CREB1 Genotypes on Individual Differences in Memory and Executive Function: Findings from the BLSA , 2017, Front. Aging Neurosci..

[22]  A. Carvalho,et al.  Genetic Studies on the Tripartite Glutamate Synapse in the Pathophysiology and Therapeutics of Mood Disorders , 2017, Neuropsychopharmacology.

[23]  Zhengxue Qiao,et al.  GNB3 and CREB1 gene polymorphisms combined with negative life events increase susceptibility to major depression in a Chinese Han population , 2017, PloS one.

[24]  D. Mohr,et al.  Major depressive disorder , 2016, Nature Reviews Disease Primers.

[25]  Kazuyuki Inoue,et al.  Influence of Genetic Polymorphisms and Concomitant Anxiolytic Doses on Antidepressant Maintenance Doses in Japanese Patients with Depression. , 2016, Biological & pharmaceutical bulletin.

[26]  Linbo Gao,et al.  Genetic variants in the promoters of let-7 family are associated with an increased risk of major depressive disorder. , 2015, Journal of affective disorders.

[27]  Kwangsik Nho,et al.  Comprehensive gene- and pathway-based analysis of depressive symptoms in older adults. , 2015, Journal of Alzheimer's disease : JAD.

[28]  I. Lyoo,et al.  Disturbance of the Glutamatergic System in Mood Disorders , 2014, Experimental neurobiology.

[29]  Hui-ling Wang,et al.  Preliminary investigation of the influence of CREB1 gene polymorphisms on cognitive dysfunction in Chinese patients with major depression , 2014, The International journal of neuroscience.

[30]  B. Penninx,et al.  Resequencing Three Candidate Genes for Major Depressive Disorder in a Dutch Cohort , 2013, PloS one.

[31]  Zhen Yan,et al.  Regulation of N-Methyl-d-aspartic Acid (NMDA) Receptors by Metabotropic Glutamate Receptor 7*♦ , 2012, The Journal of Biological Chemistry.

[32]  P. Muglia,et al.  A genome-wide significant linkage for severe depression on chromosome 3: the depression network study. , 2011, The American journal of psychiatry.

[33]  Scott F. Saccone,et al.  A 3p26-3p25 genetic linkage finding for DSM-IV major depression in heavy smoking families. , 2011, The American journal of psychiatry.

[34]  A. Serretti,et al.  A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression. , 2011, Journal of affective disorders.

[35]  Dost Öngür,et al.  Magnetic Resonance Spectroscopy Studies of Glutamate-Related Abnormalities in Mood Disorders , 2010, Biological Psychiatry.

[36]  P. Muglia,et al.  Genome-wide association study of recurrent major depressive disorder in two European case–control cohorts , 2010, Molecular Psychiatry.

[37]  S. Hamilton,et al.  The genetics of major depression: moving beyond the monoamine hypothesis. , 2010, The Psychiatric clinics of North America.

[38]  Guang Chen,et al.  Evidence for Selective microRNAs and Their Effectors as Common Long-Term Targets for the Actions of Mood Stabilizers , 2009, Neuropsychopharmacology.

[39]  N. Wray,et al.  Genomewide Association for Major Depressive Disorder: A possible role for the presynaptic protein Piccolo , 2008, Molecular Psychiatry.

[40]  J. Wierońska,et al.  Citalopram influences mGlu7, but not mGlu4 receptors' expression in the rat brain hippocampus and cortex , 2007, Brain Research.

[41]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[42]  R. Neve,et al.  Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect , 2001, Biological Psychiatry.